EPSRC funding announced to tackle resistance to antibiotics

  09 June 2021

A cross-disciplinary team from the Universities of Oxford, Ulster and UCL today announced major funding from EPSRC, part of UK Research and Innovation (UKRI), to tackle the growing challenge of Antimicrobial Resistance (AMR).

The new 5-year programme, “Beyond Antibiotics,” will start in October 2021 and bring together researchers from across the Physical and Life Sciences to develop new technology to improve both the diagnosis and treatment of bacterial infections.

Further reading: University of Oxford
Author(s): University of Oxford
Smart Innovations  
Back

OUR UNDERWRITERS

Unrestricted financial support kindly provided by

Antimicrobial Resistance Fighter Coalition

CDD VAULT Complexity Simplified





Technology Database

Display your AMR Technology, Product and Service

Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.

Read more and make your own Technology Page >>
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!